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Background: Vitamin D deficiency has been associated with a multitude of disorders including diabetes, defective
insulin secretion as well as rickets and poor bone health. Vitamin D is also a concern during childhood and
adolescence and has been reported in girls from South Brazil. We determined the prevalence of vitamin D
deficiency in girls from South Brazil and investigated whether the genotypic distribution of the BsmI, ApaI and TaqI
polymorphisms of the VDR gene and their haplotypes were associated with vitamin D levels.
Methods: Cross-sectional study including 234 apparently healthy girls aged 7 to 18 years. Height and weight were
measured for calculation of body mass index (BMI) percentiles for age. Plasma levels of 25-hydroxyvitamin D
[25(OH)D] were assessed. Participants were genotyped for ApaI (rs7975232), TaqI (rs731236), and BsmI (rs1544410)
SNPs.
Results: The median and interquartile range (25-75%) of BMI percentile was 62.0 (33.3 – 84.9). The frequency of
overweight/obesity was 24.9%. Circulating levels of 25(OH)D (≥ 30 ng/mL) were adequate in 9.4%; insufficient in
54.3% (20–29 ng/mL); and deficient in 36.3% (< 20 ng/mL). Genotype frequencies were GG= 47.0%, GA= 41.5%,
and AA= 11.5% for BsmI; GG= 16.7%, GT = 52.6%, and TT = 30.8% for ApaI; TT = 46.2%, TC = 44.9% and CC= 9.0% for
TaqI. Genotypes with no gene variance (ancestral wild genotype) of BsmI (GG vs. GA+AA, two-tailed Student’s t-test
p< 0.001), ApaI (GG vs. GT + TT, two-tailed Student’s t-test p = 0.031) and TaqI (TT vs. TC+ CC, two-tailed Student’s
t-test p = 0.005) SNPs and the GGT haplotype (two-tailed Student’s t-test p = 0.036) were significantly associated with
lower 25(OH)D levels.
Conclusions: 25-hydroxyvitamin D deficiency and insufficiency were highly prevalent in this sample. The BsmI, ApaI
and TaqI wild variants of the VDR gene, as well as the GGT haplotype, were associated with lower vitamin D levels,
suggesting that VDR gene polymorphisms could be linked to higher susceptibility to vitamin D deficiency in a
sub-population of children and adolescents.
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Vitamin D is mainly recognized for its effects on bone
metabolism and for being an important determinant of
growth and body development during childhood and
adolescence. However, a high prevalence of vitamin D
deficiency has been observed in several pediatric and* Correspondence: spritzer@ufrgs.br
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reproduction in any medium, provided the oradolescent populations [1-3] in association with over-
weight/obesity, blood pressure and glucose metabolism
[4-6]. While these studies report no gender-related dif-
ferences in vitamin D levels, recent evidence shows that
girls have significantly lower vitamin D levels than boys
[7]. Our group has also observed a high prevalence of
vitamin D deficiency in girls with precocious pubarche
and controls with normal pubertal development in South
Brazil [8].
The vitamin D receptor (VDR) gene regulates up to
200 genes [9], and mediates most effects of vitamin D
on gene expression via formation of a heterodimer withLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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of many target genes [9]. Several polymorphisms have
been described for the VDR gene (ID: 7421), located on
chromosome 12 (12q13.11), consisting of 11 exons and
spanning 63495 bp. BsmI, ApaI (both located in intron 8)
and TaqI (located in exon 9) are the most studied var-
iants. VDR gene polymorphisms have been linked with
specific health outcomes, including low bone density in
postmenopausal women [10], type 2 diabetes or metabolic
syndrome [11,12] and low 25-hydroxyvitamin D (25(OH)D)
concentration [13,14]. Given the high prevalence of vita-
min D deficiency in children and adolescents described
earlier, it may be speculated that VDR gene polymorph-
isms could be linked to higher susceptibility to develop
vitamin D deficiency.
Therefore, the aims of the present study were to assess
the genotypic distribution of the BsmI, ApaI and TaqI
polymorphisms of the VDR gene in a population of
girls from South Brazil and to determine whether these




This cross-sectional study was carried out between April
2008 and January 2011 and included 234 apparently
healthy girls aged 7 to 18 years who had parental con-
sent to participate in the study. Two hundred and thir-
teen girls recruited at four public schools from the four
main regions of the city of Curitiba (North, South, East,
and West), in the state of Paraná, Brazil (latitude −25°),
and 21 girls enrolled at a vaccination facility or Univer-
sity adolescent clinic in the city of Porto Alegre (latitude
−30°), state of Rio Grande do Sul, were included in the
study. None of the girls took calcium or vitamin D sup-
plements. Two girls used birth control pills and 19 made
occasional use of bronchodilators or nasal corticoster-
oids for asthma or rhinitis. Most of these girls were also
included in the control group of a previous study [8].
Approval for this study was obtained from the Institu-
tional Review Boards and the local Ethics Committees of
Hospital de Clínicas de Porto Alegre and Universidade
Federal do Paraná. Written informed consent was obtained
from all participants or their caretakers.
Study protocol
All subjects underwent physical examination. On that
occasion, information on thelarche and menarche age
was collected through interview. Anthropometric mea-
surements included height and weight for subsequent
calculation of body mass index (BMI). Height was
obtained by using a stadiometer fixed to the wall and
weight was obtained by using a digital balance, with
resolution of 100 grams. The subjects were evaluatedbarefoot and wearing light clothing. Individual height
and BMI values were converted into percentiles accord-
ing to age based on 2000 Centers for Disease Control and
Prevention charts [15]. For that, the software EpiInfo/
AnthropometricData (version 3.5.1) was used.
25(OH)D, the main vitamin D circulating metabolite,
was assessed in blood samples drawn between 8:00 and
10:00 AM from an antecubital vein, after an overnight
fast. Blood samples were also collected for genomic
DNA extraction.
Girls without thelarche at the time of enrollment
were defined as prepubertal. Subjects were classified
as normal weight (BMI< 85 percentile), overweight
(85 percentile ≤BMI ≤ percentile 95) or obese (BMI> 95
percentile). Serum 25(OH)D status was classified as suf-
ficient (≥ 30 ng/mL), insufficient (20–29 ng/mL) or defi-
cient (< 20 ng/mL).
Assays
Serum 25(OH)D (sensitivity = 1.5 ng/mL) was measured
with radioimmunoassay (DiaSorin, Stillwater, USA) with
intra and inter-assay coefficients of variation of <12.0%
and< 15.0% respectively.
Genotype analysis
Genomic DNA was extracted from peripheral blood
leukocytes. Molecular genotyping for the ApaI
(rs7975232) and TaqI (rs731236) SNPs (change of
the G!T and T!C, respectively) was performed by
polymerase chain reaction (PCR) followed by restriction
fragment length polymorphism (RFLP) analysis [16].
Forward 5’-GTTCAGCAGCAAATGGGACACA-3’ and
reverse 5’-AGCTTCTGGATCATCTTGGCATAG-3’, primer
sequences yielded a 740 bp PCR product. Protocol con-
ditions consisted of denaturation at 95°C for 2 min fol-
lowed by 35 cycles (95°C, 30sec; 59.2°C, 30sec; 72°C,
80sec) and final extension at 72°C for 5 min. PCR pro-
ducts were digested overnight by the restriction enzymes
ApaI or TaqI (New England Biolabs, USA) at 37°C or
65°C, respectively. ApaI digestion revealed genotypes
TT (740 bp), TG (740, 559, and 181 bp) or GG (559
and 181 pb), while TaqI digestion denoted genotypes
TT (740 bp), TC (740, 635 and 105 pb) or CC (635 and
105 pb) at 2% agarose gel electrophoresis.
BsmI (rs1544410) SNP (change of the G!A) geno-
typing was performed through real-time PCR (7500 Fast
Applied Biosystems, California, USA) with allelic dis-
crimination assays (Taqman MGB ProbesW) according to
the manufacturer’s instructions (Applied Biosystems,
California, USA).
We calculated Lewontin's D' (|D'|) r2 between each
pair of genetic markers for estimating the linkage dis-
equilibrium. Haplotypes were constructed from the com-
bination of the three VDR polymorphisms (BsmI, ApaI
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PHASE 2.1.1 program. The first letter of each haplotype
refers to BsmI polymorphism, the second to the ApaI
polymorphism, and the third to TaqI polymorphism.
Statistical analysis
The sample size estimation was based on the study by
Bhanushali et al. [13], in which a different frequency of
the SNP TaqI was found in relation to vitamin D status
in adults. Therefore, considering the same difference, an
alpha of 5% and a beta of 90%, the sample size was esti-
mated as 228 girls, 94 with genotype TT and 134 with
genotypes TC+CC.
Data were described as mean ± standard deviation
(SD) (Gaussian variables) or median and interquartile
range (25-75%) (non-Gaussian variables). Comparisons
between means were analyzed by the unpaired two-
tailed Student’s t-test or one-way analysis of variance
(ANOVA) followed by Tukey’s post hoc test. Log10
transformation was used to normalize the distribution
of non-Gaussian variables and mean values were back-
transformed for presentation. Data were adjusted by
season and/or age at the time of blood collection by lin-
ear regression.
Categorical variables and the agreement of genotype
frequencies with Hardy-Weinberg equilibrium for each
SNP were analyzed using the Pearson chi-square test
[χ2]. Odds ratios (OR) and 95% confidence intervals
(95%CI) were obtained using χ2 risk estimate. Multiple
linear regression analysis models were set up to deter-
mine the independent effects of season, age, and BMI
percentile for each of the polymorphisms (BsmI, ApaI
and TaqI) and the Ht1 haplotype, having plasma 25(OH)
D as the dependent variable. Data were considered as
statistically significant at p< 0.05. The Statistical Pack-
age for the Social Sciences 16 (SPSS, Chicago, IL) was
used in the analyses.
Results
All the 234 healthy girls who were enrolled following
parental consent completed the interview, physical
examination and blood collection. They were studied
during spring/summer [35 (15%)] or fall/winter [199
(85%)]. Mean chronological age was 13.0 ± 1.9 years. The
median BMI percentile was 61.9 (33.3 - 84.9). The fre-
quency of overweight was 15.7%, and of obesity 9.2%.
Only 4.0% of the participants were prepubertal, and
34.2% had not had menarche.
Table 1 shows clinical features and 25(OH)D levels in
girls according to tertiles of age. Height and BMI per-
centiles were adequate for all age categories. 25(OH)D
levels did not differ among age categories. Mean serum
25(OH)D was 21.3±6.8 ng/mL. Stratification by 25(OH)D
status revealed sufficient circulating levels (≥ 30 ng/mL)in only 9.4% of the overall group; 54.3% were insufficient
(20–29 ng/mL) and 36.3% were deficient (< 20 ng/mL).
No associations were found between season at the
time of the blood collection and 25(OH)D levels (spring/
summer= 21.4 ± 6.7 ng/mL vs. fall/winter = 21.3 ± 6.9 ng/
mL; p = 0.955). No significant differences were found
between season at the time of the blood collection and
25(OH)D status (χ2 = 0.249; p = 0.883).
Concerning VDR polymorphisms, all three SNPs
(BsmI, ApaI and TaqI) were in Hardy-Weinberg equilib-
rium. Genotype frequencies were GG= 47.0% (n = 110),
GA=41.5% (n = 97), and AA= 11.5% (n = 27) for BsmI
SNP; GG= 16.7% (n = 39), GT= 52.6% (n = 123), and
TT=30.8% (n = 72) for ApaI SNP; TT=46.2% (n = 108),
TC= 44.9% (n = 105), and CC= 9.0% (n = 21) for TaqI
SNP. Twenty-one randomly selected samples (around
10%) were genotyped twice, and the reproducibility of
genotyping was 100%.
The BsmI (G!A) polymorphism was in partial link-
age disequilibrium with the ApaI (G!T) polymorphism
(|D’| = 0.964; r2 = 0.330), and in almost complete link-
age disequilibrium with the TaqI (T!C) polymorphism
(|D’| = 0.919; r2 = 0.807). The ApaI (G!T) polymorph-
ism was also in partial linkage disequilibrium with the
TaqI (T!C) polymorphism (|D’| = 0.970; r2 = 0.319).
Seven haplotypes were inferred in the sample (Ht1:
GGT, Ht2: GGC, Ht3: GTT, Ht4: GTC, Ht5: AGT,
Ht6: ATT and Ht7: ATC). Haplotype frequencies were
Ht1: 0.419; Ht2: 0.004; Ht3: 0.242; Ht4: 0.013; Ht5:
0.006; Ht6: 0.019 and Ht7: 0.297.
No differences were found in age, height and BMI per-
centiles, age at menarche or at thelarche between geno-
types for all the three polymorphisms. In contrast,
presence of the wild-type genotypes BsmI, ApaI and
TaqI SNPs of the VDR gene was significantly associated
with lower 25(OH)D levels (BsmI p< 0.001; ApaI
p = 0.031; TaqI p = 0.005), even after adjustment for sea-
son at the time of blood collection and age (Figure 1).
Compared to the wild genotype, 25(OH)D deficiency
(< 20 ng/mL) was less frequent with BsmI GA+AA
(p = 0.014) and TaqI TC+CC (p = 0.034) genotypes
(Figure 2). The OR for 25(OH)D deficiency among girls
with the wild genotype was 1.96 (95%CI: 1.14–3.37)
and 1.78 (95%CI: 1.04–3.06), for BsmI and TaqI SNPs,
respectively. There was no difference in frequency
of 25(OH)D deficiency between ApaI polymorphisms
and the wild genotype (Figure 2) (95%CI: 0.27–1.08;
p = 0.078).
In addition, taking into consideration the haplotype
frequencies and the results for individual polymorphism
analyses, Ht1 was considered as the risk haplotype
and Ht7 as the protective haplotype for circulating
25(OH)D levels. Patients with two copies of Ht1 (Ht1/
Ht1) presented lower 25(OH)D levels as compared to
Table 1 Anthropometric and clinical features of girls according to tertiles of age
Age in years (tertile)
Variable <12.04 (77) 12.04-14.05 (80) >14.05 (77) p
Age (years) 10.9 ± 1.1a 13.0 ± 0.6a 15.2 ± 1.1a <0.001
*Height percentile 66.21 (39.99-82.14) 55.65 (31.45-74.40) 41.87 (19.75-77.13) 0.066
*BMI percentile 62.9 (31.8-86.4) 59.9 (35.1-85.1) 61.8 (31.7-82.1) 0.967
Age at thelarche (years) 9.9 ± 1.0a 10.3 ± 1.1 10.5 ± 1.2a 0.013
Age at menarche (years) 10.9 ± 1.2a 11.6 ± 1.0b 12.1 ± 1.3ab 0.002
25(OH)D (ng/mL) 20.77 ± 6.97 22.10 ± 6.01 21.09 ± 7.33 0.492
Values are expressed as mean± SD or median and interquartile range (25-75%).
p value by one-way analysis of variance (ANOVA).
* Log10 transformation.
Equal letters mean statistical difference between groups.
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(19.16±7.08 vs. 21.70±6.66 ng/mL, p=0.036) and patients
having one copy of Ht1 and one copy of Ht7 (Ht1/Ht7)
or two copies of Ht7 (Ht7/Ht7) (22.68±6.34 ng/mL,
p= 0.008), even after adjustment for season at the time
of the blood collection and age.
Multiple linear regression analysis assessing the effects
of season, age, BMI percentile, and polymorphic geno-
types on plasma 25(OH)D are shown in Table 2. BsmI,
ApaI and TaqI polymorphisms, Ht1 haplotype (GGT)
and age were significant independent predictors of plasma
25(OH)D, explaining 7.4%, 4.3%, 5.6% and 4.4% of vari-
ance in plasma 25(OH)D concentrations, respectively.
Discussion
In the present study, a high prevalence of vitamin D
deficiency or insufficiency was found in 7 to 18-year
old girls from South Brazil. In addition, VDR wild-type
genotypes BsmI, ApaI and TaqI were associated with
lower 25(OH)D levels both individually and as the GGT
haplotype, even after adjustment for age and season
at the time of blood collection, and were independent
positive predictors of 25(OH)D levels. To the best of
our knowledge, this is the first report relating VDR
gene polymorphisms and haplotypes to 25(OH)D levelsFigure 1 Vitamin D levels according to BsmI (A), ApaI (B), and TaqI (C
Values are expressed as means (central circle) and 95% CI (lower and uppe
GA+AA (n = 124); ApaI GG (n= 39) and GT + TT (n = 195); TaqI TT (n = 108)in healthy children and adolescent girls from the gen-
eral population.
Previous studies have reported low levels of 25(OH)D
in different pediatric and adolescent populations [2,3].
In our sample, only 9.4% of the participants had
adequate circulating concentrations of 25(OH)D, which
is far below the 39.0% reported for a 16–20 year old
population from a rural town in the state of São Paulo,
Brazil (latitude −23°) [17]. Since the latitude and solar
radiation are similar in the cities included in those pre-
vious studies and in the cities studied by us, diverse diet-
ary habits and the age of participants may explain the
discrepancies in the frequency of sufficient 25(OH)D
status. In this sense, one limitation of the present study is
the lack of control for some confounders, such as dietary
vitamin D intake and duration of sun exposure. However,
no associations were found between 25(OH)D levels and
season at the time of blood collection. One potential
explanation for the lack of seasonal difference is that
below a latitude of approximately 35°, UVB radiation is
sufficient for vitamin D synthesis all year round [18].
Concerning young populations, several studies have
shown that vitamin D levels are lower in the presence
of overweight/obesity, and that low levels of 25(OH)D
could influence the risk of developing metabolic disorders) SNPs in VDR gene grouped by presence of polymorphic allele.
r limit). Two-tailed Student’s t-test, *p< 0.05 BsmI GG (n = 110) and
and TC+CC (n = 126).
Figure 2 Frequency of vitamin D deficiency according to BsmI (A), ApaI (B), and TaqI (C) SNPs in VDR gene grouped by presence of
polymorphic allele. White bars express the frequency of vitamin D status (deficiency or insufficiency/sufficiency) for the wild genotype of
each VDR SNP. Gray bars express the frequency of vitamin D status for the polymorphic (in heterozygous plus homozygous) genotypes.
Pearson chi-square test, *p< 0.05.
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populations [4-6]. Obesity associated-vitamin D insuffi-
ciency is likely caused by deposition of skin and dietary
vitamin D3 in body fat compartments, resulting in
decreased bioavailability [19].
In addition, studies have shown that obese girls with








Season −0.082 ± 1.249 0.948 0.074
Age (years) 0.469 ± 0.225 0.038
*BMI percentile −0.004 ± 0.015 0.804
BsmI GG vs. GA+AA 3.114 ± 0.881 <0.001
Model 2
Season −0.149 ± 1.270 0.907 0.043
Age (years) 0.518 ± 0.228 0.024
*BMI percentile −0.005 ± 0.016 0.739
ApaI GG vs. GT+ TT 2.575 ± 1.189 0.031
Model 3
Season −0.131 ± 1.261 0.917 0.056
Age (years) 0.497 ± 0.227 0.030
*BMI percentile −0.005 ± 0.015 0.732
TaqI TT vs. TC+CC 2.505 ± 0.890 0.005
Model 4
Season −0.115 ± 1.268 0.928 0.044
Age (years) 0.510 ± 0.228 0.027
*BMI percentile −1.098 ± 1.382 0.428
Ht1 haplotype vs. Ht1/0 + 0/0 2.632 ± 1.218 0.032
* Log10 transformation.[4], and adolescents with reduced levels of vitamin D
had increased risk of metabolic syndrome [5]. Moreover,
a recent study with children aged 8 to 18 years, in which
47% were obese, reported a negative association between
BMI, percentage of body fat, subcutaneous and visceral
adipose tissue and 25(OH)D levels in white and black
subjects [3]. Despite the age similarity, the frequency of
obesity was very low in our sample, and therefore we
were unable to assess these associations.
Only a few studies are available in the literature relat-
ing VDR polymorphisms and 25(OH)D levels, especially
in young and healthy populations. In a study with ado-
lescent girls, the BsmI polymorphism was marginally,
but not significantly, associated with 25(OH)D levels
[20]. Regarding adult populations, the results are con-
flicting. In India, one study reported that TaqI poly-
morphism was associated with higher 25(OH)D levels in
healthy adults aged 25 to 60 years [13], while another
study analyzing BsmI and TaqI SNPs did not confirm
this association [21]. In addition, other SNPs in different
regions of the VDR gene have been associated with
levels of 25(OH)D in adolescent girls [20] and other
populations [14].
In contrast, studies focusing on specific conditions,
such as the overweight Insulin Resistance Atheroscler-
osis family study, in which only the BsmI SNP [22] was
analyzed, or the Metabolites in Multiple Sclerosis study,
covering ApaI and TaqI SNPs [23], did not find an asso-
ciation between VDR polymorphism and 25(OH)D
levels. However, these studies were carried out with dis-
ease-affected adult populations, whereas our results refer
to younger, healthy subjects. In studies with older over-
weight subjects, BsmI, ApaI, and TaqI SNPs of VDR
gene were not associated with 25(OH)D levels. Never-
theless, the lack of association may be explained, at least
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study were using vitamin D supplements [24,25].
VDR gene polymorphisms have also been studied in
some other conditions. BsmI, ApaI, and TaqI poly-
morphic genotypes were associated with suppressed
cytokine response in pulmonary tuberculosis [26] and
appear to be related with higher glucose levels [12] and
diabetes [27,28]. ApaI gene variant has been linked to
higher bone metabolism and bone mineral density [10].
We also have recently described that the wild genotype
of the ApaI polymorphism is more frequent in girls with
precocious pubarche than in controls with normal pu-
bertal development [8].
The BsmI, ApaI and TaqI polymorphism are located at
the 3’ untranslated region (3′ UTR) of the VDR gene.
The BsmI and ApaI SNPs are located in intron 8, and
TaqI is a silent SNP in exon 9. Although 3’ UTR has
been recognized as a region involved in the modulation
of gene expression, especially through the regulation of
mRNA stability and efficiency of protein translation [29],
the functional role of the BsmI, ApaI, and TaqI VDR
gene polymorphisms has not been established. Moreover,
the most common haplotype for the VDR gene in the
present study (Ht1) is the same found in Caucasians and
Asians, followed by Ht7 and Ht3, as found for Cauca-
sians [30]. A strong linkage disequilibrium between these
three SNPs has been shown in the present and previous
studies in different populations [31].
In the present study, girls with the wild genotype for
BsmI and TaqI SNPs or presenting the Ht1 haplotype
were found to be at higher risk for 25(OH)D deficiency.
In turn, Ht7 was regarded as the protective haplotype
for circulating 25(OH)D levels. Therefore, it is possible
to hypothesize that the VDR genotype influences the
susceptibility to vitamin D deficiency in children and
adolescents. Thus, the present results open new possibil-
ities for further studies in this field, especially on the
genotype-related mechanisms of calcium and vitamin D
metabolism and prevention of 25(OH)D deficiency in
young subjects.Conclusions
In conclusion, data from this study confirm the high
prevalence of vitamin D deficiency and insufficiency in
children and adolescent populations. The present find-
ings also suggest that the BsmI, ApaI and TaqI wild var-
iants of the VDR gene and the GGT haplotype are
associated with lower 25(OH)D levels. Further studies
with populations of different ethnic origins are needed
to confirm the clinical relevance of the present results.
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